Yield10 Bioscience Inc

Company Profile

Yield10 Bioscience Inc had its IPO on 2006-11-10 under the ticker symbol YTEN.

The company operates in the Basic Materials sector and Agricultural Inputs industry. Yield10 Bioscience Inc has a staff strength of 30 employees.

Stock update

Shares of Yield10 Bioscience Inc opened at $0.36 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.34 - $0.36, and closed at $0.35.

This is a +2.09% increase from the previous day's closing price.

A total volume of 67,455 shares were traded at the close of the day’s session.

In the last one week, shares of Yield10 Bioscience Inc have increased by +2.09%.

Yield10 Bioscience Inc's Key Ratios

Yield10 Bioscience Inc has a market cap of $4.09 million, indicating a price to book ratio of 1.2806 and a price to sales ratio of 16.8007.

In the last 12-months Yield10 Bioscience Inc’s revenue was $258000 with a gross profit of $-7300000 and an EBITDA of $-13881000. The EBITDA ratio measures Yield10 Bioscience Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Yield10 Bioscience Inc’s operating margin was -5488.76% while its return on assets stood at -87.88% with a return of equity of -262.57%.

In Q2, Yield10 Bioscience Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 59.7%.

Yield10 Bioscience Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

0

Its diluted EPS in the last 12-months stands at $-2.69 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Yield10 Bioscience Inc’s profitability.

Yield10 Bioscience Inc stock is trading at a EV to sales ratio of 9.1003 and a EV to EBITDA ratio of -0.3615. Its price to sales ratio in the trailing 12-months stood at 16.8007.

Yield10 Bioscience Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$5.87 million

Total Liabilities

$2.47 million

Operating Cash Flow

$0

Capital Expenditure

$18000

Dividend Payout Ratio

0%

Yield10 Bioscience Inc ended 2024 with $5.87 million in total assets and $0 in total liabilities. Its intangible assets were valued at $5.87 million while shareholder equity stood at $587000.00.

Yield10 Bioscience Inc ended 2024 with $0 in deferred long-term liabilities, $2.47 million in other current liabilities, 61000.00 in common stock, $-407160000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $2.34 million and cash and short-term investments were $2.34 million. The company’s total short-term debt was $686,000 while long-term debt stood at $971000.00.

Yield10 Bioscience Inc’s total current assets stands at $3.03 million while long-term investments were $0 and short-term investments were $0.00. Its net receivables were $0 compared to accounts payable of $467000.00 and inventory worth $0.

In 2024, Yield10 Bioscience Inc's operating cash flow was $0 while its capital expenditure stood at $18000.

Comparatively, Yield10 Bioscience Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.35

52-Week High

$4.19

52-Week Low

$0.31

Analyst Target Price

$2.83

Yield10 Bioscience Inc stock is currently trading at $0.35 per share. It touched a 52-week high of $4.19 and a 52-week low of $4.19. Analysts tracking the stock have a 12-month average target price of $2.83.

Its 50-day moving average was $1.23 and 200-day moving average was $2.34 The short ratio stood at 0.3 indicating a short percent outstanding of 0%.

Around 1812% of the company’s stock are held by insiders while 805.8% are held by institutions.